TEVA-IRBESARTAN HCTZ
TEVA CANADA LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is TEVA-IRBESARTAN HCTZ discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that TEVA-IRBESARTAN HCTZ 300MG 25MG has been permanently discontinued (last updated June 29, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is TEVA-IRBESARTAN HCTZ not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02330539
Strength
300MG 25MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
IRBESARTAN HYDROCHLOROTHIAZIDE
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Business reasons
Disruption of the manufacture of the drug.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646